Reach Us +44-1235-425476
Editor - Prashansa Agrawal | The University of Arizona | 15649
ISSN: 2329-6887

Journal of Pharmacovigilance
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Prashansa Agrawal

Prashansa Agrawal
Prashansa Agrawal
University of Arizona
Read Interview session with Prashansa Agrawal
The University of Arizona


Dr. Prashansha Agrawal is working on anticancer drug targets for quite a couple of years. She has received her PhD degree from Indian Institute of Technology Roorkee, India, where she worked on drug-DNA interaction studies to find out the potential targets for anticancer drugs, which may provide an insight into the rationale for structurally based drug design. After that she joined University of Tennessee as postdoc, where she worked on soluble CD14 (sCD14), which is a serum glycol protein that binds to the Lipid A moiety of lipopolysaccharides (LPS) with high affinity as part of the innate immune response to bacterial endotoxins. Now she has joined University of Arizona and she is working on structure elucidation of DNA G-quadruplex secondary structure that has recently emerged as a new class of cancer-specific molecular targets for cancer therapeutics. Her work is published in peer-reviewed journals and she has been a reviewer for few scientific journals.

Research Interest

Structural biology, computational biology, drug discovery and development, pharmacology, molecular biology, NMR spectroscopy, Chemical Biology, Biophysics, macromolecular interactions



Global Speakers in the subject

Global Experts in the subject


Artificial Intelligence in Drug Discovery and Development

Prashansa Agrawal
Editorial: J Pharmacovigil 2018, 6:e173
DOI: 10.4172/2329-6887.1000e173

Journal of Pharmacovigilance - Structure-based Drug Design

Structure-based Drug Design : Nucleic Acids as anti-cancer drug target

Presented by: Prashansa Agrawal
University of Arizona

Download PPT PPT Views: 402 Updated on: 2015-10-20 For Recent Update: Click here
Download PDF   PDF Views: 402  Updated on: 2015-10-20 For Recent Update: Click here